Study of GDC-0941 or GDC-0980 With Fulvestrant Versus Fulvestrant in Advanced or Metastatic Breast Cancer in Participants Resistant to Aromatase Inhibitor Therapy
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Fulvestrant|DRUG: GDC-0941|DRUG: GDC-0941 Matching Placebo|DRUG: GDC-0980|DRUG: GDC-0980 Matching Placebo
Sponsor: Genentech, Inc.